These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33235218)

  • 1. Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer.
    Rinaldetti S; Worst TS; Rempel E; Kriegmair MC; Hartmann A; Porubsky S; Bolenz C; Erben P
    Sci Rep; 2020 Nov; 10(1):20472. PubMed ID: 33235218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
    Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
    J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
    Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
    Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
    Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
    Dudek AM; Boer SJ; Boon N; Witjes JA; Kiemeney LALM; Verhaegh GW
    Oncotarget; 2017 May; 8(21):34442-34452. PubMed ID: 28415801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
    de Jong JJ; Liu Y; Robertson AG; Seiler R; Groeneveld CS; van der Heijden MS; Wright JL; Douglas J; Dall'Era M; Crabb SJ; van Rhijn BWG; van Kessel KEM; Davicioni E; Castro MAA; Lotan Y; Zwarthoff EC; Black PC; Boormans JL; Gibb EA
    Genome Med; 2019 Oct; 11(1):60. PubMed ID: 31619281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
    Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis.
    de Jong JJ; Valderrama BP; Perera J; Juanpere N; Cejas P; Long H; Albà MM; Gibb EA; Bellmunt J
    Br J Cancer; 2022 Jul; 127(2):313-320. PubMed ID: 35449454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
    Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
    DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.
    Rinaldetti S; Wirtz RM; Worst TS; Eckstein M; Weiss CA; Breyer J; Otto W; Bolenz C; Hartmann A; Erben P
    Oncotarget; 2017 Jul; 8(29):47595-47606. PubMed ID: 28498805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of long noncoding RNAs as biomarkers in urothelial carcinoma.
    Droop J; Szarvas T; Schulz WA; Niedworok C; Niegisch G; Scheckenbach K; Hoffmann MJ
    PLoS One; 2017; 12(4):e0176287. PubMed ID: 28430799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
    Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer.
    Sheng H; Zhang G; Huang Y; Sun L; Shi G; Ye D
    Dis Markers; 2021; 2021():8839747. PubMed ID: 33688381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
    Jiang B; Hailong S; Yuan J; Zhao H; Xia W; Zha Z; Bin W; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():500-507. PubMed ID: 30243082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening.
    Rinaldetti S; Rempel E; Worst TS; Eckstein M; Steidler A; Weiss CA; Bolenz C; Hartmann A; Erben P
    Oncotarget; 2018 May; 9(40):25935-25945. PubMed ID: 29899832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Efstathiou JA; Mouw KW; Gibb EA; Liu Y; Wu CL; Drumm MR; da Costa JB; du Plessis M; Wang NQ; Davicioni E; Feng FY; Seiler R; Black PC; Shipley WU; Miyamoto DT
    Eur Urol; 2019 Jul; 76(1):59-68. PubMed ID: 30712971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.